Muscle strength recovery in treated Guillain-Barré syndrome: A prospective study for the first 18 months after onset

American Journal of Physical Medicine and Rehabilitation

Volumn 86, Issue 9, 2007, Pages 716-724

  El Mhandi, Lhassan ^a,b   Calmels, Paul ^a   Camdessanché, Jean Philippe ^a   Gautheron, Vincent ^a   Féasson, Leonard ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b SERVICE DE NEUROLOGIE   (France)

Author keywords

Acute Immune Polyneuropathy; Disability; Muscle; Rehabilitation

Indexed keywords

IMMUNOGLOBULIN;

ADULT; CLINICAL ARTICLE; CONVALESCENCE; DISEASE COURSE; ELBOW FLEXION; FEMALE; FLEXOR MUSCLE; FUNCTIONAL ASSESSMENT; GUILLAIN BARRE SYNDROME; HUMAN; ISOKINETIC EXERCISE; ISOMETRIC EXERCISE; KNEE FUNCTION; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; PATIENT SATISFACTION; PATIENT TRANSPORT; PLASMAPHERESIS; PROSPECTIVE STUDY; REHABILITATION CENTER; REVIEW; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; PROGNOSIS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 34548132387     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31813e0b67     Document Type: Review

References (29)

1. Alter M: The epidemiology of Guillain-Barre syndrome. Ann Neurol 1990;27(suppl):S7-12
2. Cosi V, Versino M: Guillain-Barre syndrome. Neurol Sci 2006;27(suppl 1):S47-51
3. Horowitz SH: The idiopathic polyradiculoneuropathies: a historical guide to an understanding of the clinical syndromes. Acta Neurol Scand 1989;80:369-86
4. Meythaler JM, DeVivo MJ, Braswell WC: Rehabilitation outcomes of patients who have developed Guillain-Barre syndrome. Am J Phys Med Rehabil 1997;76:411-9
5. Bernsen RA, de Jager AE, Schmitz PI, van der Meche FG: Long-term impact on work and private life after Guillain-Barre syndrome. J Neurol Sci 2002;201:13-7
6. Burrows DS, Cuetter AC: Residual subclinical impairment in patients who totally recovered from Guillain-Barre syndrome: impact on military performance. Mil Med 1990;155:438-40
7. Dornonville de la Cour C, Jakobsen J: Residual neuropathy in long-term population-based follow-up of Guillain-Barre syndrome. Neurology 2005;64:246-53
8. Forsberg A, Press R, Einarsson U, de Pedro-Cuesta J, Widen Holmqvist L: Impairment in Guillain-Barre syndrome during the first 2 years after onset: a prospective study. J Neurol Sci 2004;227:131-8
9. Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA: Connecting impairment, disability, and handicap in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2003;74:99-104
10. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM: Controlled trial prednisolone in acute polyneuropathy. Lancet 1978;2:750-3
11. Miller RG, Peterson C, Rosenberg NL: Electrophysiologic evidence of severe distal nerve segment pathology in the Guillain-Barre syndrome. Muscle Nerve 1987;10:524-9
12. Pitetti KH, Barrett PJ, Abbas D: Endurance exercise training in Guillain-Barre syndrome. Arch Phys Med Rehabil 1993;74:761-5
13. Dornonville de la Cour C, Andersen H, Stalberg E, Fuglsang-Frederiksen A, Jakobsen J: Electrophysiological signs of permanent axonal loss in a follow-up study of patients with Guillain-Barre syndrome. Muscle Nerve 2005;31:70-7
14. Hiraga A, Mori M, Ogawara K, et al: Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2005;76:719-22
15. Raphael JC, Masson C, Morice V, et al: The Landry-Guillain-Barre syndrome. Study of prognostic factors in 223 cases [in French]. Rev Neurol (Paris) 1986;142:613-24
16. Vedeler CA, Wik E, Nyland H: The long-term prognosis of Guillain-Barre syndrome. Evaluation of prognostic factors including plasma exchange. Acta Neurol Scand 1997;95:298-302
17. Cheng Q, Jiang GX, Press R, et al: Clinical epidemiology of Guillain-Barre syndrome in adults in Sweden 1996-97: a prospective study. Eur J Neurol 2000;7:685-92
18. Rees JH, Thompson RD, Smeeton NC, Hughes RA: Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998;64:74-7
19. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients. The Italian Guillain-Barre Study Group. Brain 1996;119:2053-61
20. Chio A, Cocito D, Leone M, Giordana MT, Mora G, Mutani R: Guillain-Barre syndrome: a prospective, population-based incidence and outcome survey. Neurology 2003;60:1146-50
21. de Jager AE, Minderhoud JM: Residual signs in severe Guillain-Barre syndrome: analysis of 57 patients. J Neurol Sci 1991;104:151-6
22. Asbury AK, Cornblath DR: Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(suppl):S21-4
23. Bohannon RW: Manual muscle test scores and dynamometer test scores of knee extension strength. Arch Phys Med Rehabil 1986;67:390-2
24. Elmhandi L, Feasson L, Camdessanche JP, Calmels P, Gautheron V: Isokinetic assessment of muscular strength in subjects with acute inflammatory demyelinating polyradiculoneuropathy [in French]. Ann Readapt Med Phys 2004;47:209-16
25. Ottenbacher KJ, Hsu Y, Granger CV, Fiedler RC: The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil 1996;77:1226-32
26. Milner-Brown HS, Stein RB, Lee RG: Contractile and electrical properties of human motor units in neuropathies and motor neurone disease. J Neurol Neurosurg Psychiatry 1974;37:670-6
27. Hiraga A, Mori M, Ogawara K, Hattori T, Kuwabara S: Differences in patterns of progression in demyelinating and axonal Guillain-Barre syndromes. Neurology 2003;61:471-4
28. Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA: Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology 1999;53:1648-54
29. Feasson L, Camdessanche JP, El Mhandi L, Calmels P, Millet GY: Fatigue and neuromuscular diseases. Ann Readapt Med Phys 2006;49:289-300, 375-84